trial

Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia

NCTId NCT07477301
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 46 (actual)
Sponsored by Hasanuddin University
Primary completion 2025-02-28
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
46 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-12-01
Primary completion
2025-02-28
Eligibility
MALE · 20 Years · 45 Years

Interventions & indications

Drugs
Structured Supportive PsychotherapyRisperidone

Sponsors

Hasanuddin UniversityLead Sponsor

Investigators

2
Agus Durman, MDPrincipal Investigator
Indrawaty Suhuyanli, MDStudy Chair

Sites

1 total
Makassar, Indonesia

Linked catalysts

1
Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and In — primary completion2025-02-28

Facts & assertions

4 sourced
Enrollment
46
Phase
PHASE2
Primary Completion Date
2025-02-28
Status
COMPLETED
relationships
The graph out of here
drug
Structured Supportive Psychotherapy
drug
Risperidone
drug
lead_sponsor
Hasanuddin University
company
indication
Cognitive Dysfunction
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Agus Durman, MD
person
Indrawaty Suhuyanli, MD
person